Hot Investor Mandate: Japan Headquartered Global Company Invests in Medtech & Digital Health Companies in CNS, Oncology, Cardiovascular Diseases, and More

21 Jan

A firm headquartered in Tokyo, Japan, operates globally and providing medical solutions in more than 160 countries. Their venture funding activities are based in several offices throughout USA and China. Typical allocation sizes range from $1M-$10M, and may be structured as research funds, equity, or convertible loans depending on the phase of development. The firm will consider companies at all stages from concept to commercial.

The firm is interested in medical technology, diagnostics and digital health companies across indications including cardio, neuro, and peripheral vascular diseases, heart failure, stroke and oncology.

The firm may or may not seek a board seat on companies they invest in. They are open to working with all management teams, and view deals globally.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: